Therapeutic cannabis

Understanding the stakes of medical cannabis

Therapeutic cannabis

Understanding the stakes of medical cannabis

Therapeutic cannabis

Understanding the stakes of medical cannabis

The resurgence of an ancestral plant

  • -5000 av.B.C.

    Presence of cannabis in several ancient medical treatises

  • Until the end of the 19th century

    Traditional use of cannabis in medicine

  • 1953

    Withdrawal of cannabis in the French Pharmacopoeia

  • 1964

    Identification of the component molecules of cannabis by Raphaël Mechoulam and verification of their efficacy in the treatment of various diseases.

  • 1990

    Discovery of the endocannabinoid system which suggests that "the active ingredients of cannabis could be used to treat chronic pain and neurological disorders" (NASEM, 2017).

  • 2020

    The United Nations Commission on Narcotic Drugs has recognized the therapeutic effects of cannabis.

The resurgence of an ancestral plant

  • -5000 av.B.C.

    Presence of cannabis in several ancient medical treatises

  • Until the end of the 19th

    Traditional use of cannabis in medicine

  • 1953

    Withdrawal of cannabis in the French Pharmacopoeia

  • 1964

    Identification of the component molecules of cannabis by Raphaël Mechoulam and verification of their efficacy in the treatment of various diseases.

  • 1990

    Discovery of the endocannabinoid system which suggests that "the active ingredients of cannabis could be used to treat chronic pain and neurological disorders" (NASEM, 2017).

  • 2020

    The United Nations Commission on Narcotic Drugs has recognized the therapeutic effects of cannabis.

Therapeutic use, a universal plant

Cannabis has been used in medicine for several hundred years. First of all, different ethnic groups and societies have made use of it. It was in the seventeenth century that cannabis entered western medicine for the treatment of epilepsy, migraines, neuralgia, convulsions, spasms and other ailments.

For various reasons (inconstancy of the therapeutic activity of cannabis, difficulty in fixing the dosage, etc.), treatments disappeared in the first half of the 20th century. It is around 1970, following various works, that the interest for this plant reappeared. A high number of claims about therapeutic benefits have led to an increasing number of therapists supporting the use of cannabis to treat certain physical and mental illnesses.

Cannabis today

At the international level, in reviewing a series of World Health Organization (OMS) recommendations on cannabis and its derivatives, the United Nations Commission on Narcotic Drugs (CND) decided to remove it from Schedule IV of the Single Convention on Narcotic Drugs of 1961.

On the national territory, the health authorities have set up a therapeutic cannabis program. The work of successive committees of the French National Agency for the Safety of Medicines (ANSM) has paved the way for an experiment that will soon allow 3,000 patients to benefit from a therapeutic cannabis prescription.

Cannabis today

Cannabis today

At the international level, in reviewing a series of World Health Organization (OMS) recommendations on cannabis and its derivatives, the United Nations Commission on Narcotic Drugs (CND) decided to remove it from Schedule IV of the Single Convention on Narcotic Drugs of 1961.

On the national territory, the health authorities have set up a therapeutic cannabis program. The work of successive committees of the French National Agency for the Safety of Medicines (ANSM) has paved the way for an experiment that will soon allow 3,000 patients to benefit from a therapeutic cannabis prescription.

Innovations to come

The level of knowledge in the different areas of medical use of cannabis and cannabinoids is very heterogeneous.

Pre-clinical and clinical trials on certain cannabinoids should be conducted to support the use of cannabis products.

Innovations to come

Innovations to come

The level of knowledge in the different areas of medical use of cannabis and cannabinoids is very heterogeneous.

Pre-clinical and clinical trials on certain cannabinoids should be conducted to support the use of cannabis products.

error: Contenu protégé!

Venez découvrir notre nouveau site internet. Nous souhaitons que les professionnels de santé qui souhaitent se renseigner sur le cannabis médical aient accès aux dernières recherches scientifiques pour aider les patients en impasse thérapeutique.

Cet espace membre est exclusivement réservé aux professionnels de santé pour la formation du cannabis médical. Il permettra d'accompagner la création d'un programme intelligent du cannabis médical en France .
Si votre candidature est acceptée vous recevrez un mail de confirmation avec vos codes d’accès.